Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2018, Article ID 5823870, 5 pages
https://doi.org/10.1155/2018/5823870
Research Article

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?

Department of Urology, Eberhard Karls University, Tuebingen, Germany

Correspondence should be addressed to Tilman Todenhöfer; ed.negnibeut-inu.dem@refeohnedot.namlit

Received 13 August 2017; Accepted 4 December 2017; Published 30 January 2018

Academic Editor: Jasmin Bektic

Copyright © 2018 Simone Bier et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Eltz, E. Comperat, O. Cussenot, and M. Roupret, “Molecular and histological markers in urothelial carcinomas of the upper urinary tract,” BJU International, vol. 102, no. 5, pp. 532–535, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Roupret, M. Babjuk, E. Comperat et al., “European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update,” European Urology, vol. 68, no. 5, pp. 868–879, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Marin-Aguilera, L. Mengual, M. J. Ribal et al., “Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma,” European Urology, vol. 51, no. 2, pp. 409–415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. P. Rojas, S. M. Castle, C. A. Llanos et al., “Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma,” Urologic Oncology: Seminars and Original Investigations, vol. 31, no. 8, pp. 1696–1700, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Jovanovic, I. Soldatovic, A. Janjic et al., “Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors,” Urologia Internationalis, vol. 87, no. 2, pp. 134–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Todenhofer, J. Hennenlotter, M. Esser et al., “Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer,” Disease Markers, vol. 2014, Article ID 973406, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Messer, S. F. Shariat, J. C. Brien et al., “Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma,” BJU International, vol. 108, no. 5, pp. 701–705, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Mian, G. Mazzoleni, S. Vikoler et al., “Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours,” European Urology, vol. 58, no. 2, pp. 288–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. N. Papanicolaou and V. F. Marshall, “Urine sediment smears as a diagnostic procedure in cancers of the urinary tract,” Science, vol. 101, no. 2629, pp. 519-520, 1945. View at Publisher · View at Google Scholar
  10. B. R. Kipp, H. L. Tyner, M. B. Campion et al., “Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer,” American Journal of Clinical Pathology, vol. 130, no. 4, pp. 552–559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Mian, A. Pycha, H. Wiener, A. Haitel, M. Lodde, and M. Marberger, “Immunocyt1: a new tool for detecting transitional cell cancer of the urinary tract,” The Journal of Urology, vol. 161, no. 5, pp. 1486–1489, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. S. F. Shariat, M. J. Marberger, Y. Lotan et al., “Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer,” The Journal of Urology, vol. 176, no. 3, pp. 919–926, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. L. Greene, A. Berry, and B. R. Konety, “Diagnostic utility of the immunoCyt/uCyt+ test in bladder cancer,” Reviews in Urology, vol. 8, no. 4, pp. 190–197, 2006. View at Google Scholar
  14. F. Audenet, D. R. Yates, O. Cussenot, and M. Roupret, “The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC),” Urologic Oncology: Seminars and Original Investigations, vol. 31, no. 4, pp. 407–413, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Todenhofer, J. Hennenlotter, V. Tews et al., “Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma,” Urologic Oncology, vol. 31, no. 7, pp. 1148–1154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. F. A. Yafi, F. Brimo, J. Steinberg, A. G. Aprikian, S. Tanguay, and W. Kassouf, “Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer,” Urologic Oncology: Seminars and Original Investigations, vol. 33, no. 2, pp. 66.e25–66.e31, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. D. R. Siemens, A. Morales, B. Johnston, and L. Emerson, “A comparative analysis of rapid urine tests for the diagnosis of upper urinary tract malignancy,” The Canadian Journal of Urology, vol. 10, no. 1, pp. 1754–1758, 2003. View at Google Scholar
  18. B. Luo, W. Li, C. H. Deng et al., “Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma,” Cancer Genetics and Cytogenetics, vol. 189, no. 2, pp. 93–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. W. T. Huang, L. Y. Li, J. Pang et al., “Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology,” Neoplasma, vol. 59, no. 4, pp. 355–360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Akkad, A. Brunner, L. Pallwein et al., “Fluorescence in situ hybridization for detecting upper urinary tract tumors—a preliminary report,” Urology, vol. 70, no. 4, pp. 753–757, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Mischinger, L. P. Guttenberg, J. Hennenlotter et al., “Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization,” Journal of Cancer Research and Clinical Oncology, vol. 143, no. 4, pp. 677–685, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Gruschwitz, M. Gajda, A. Enkelmann et al., “FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers,” International Urology and Nephrology, vol. 46, no. 9, pp. 1769–1774, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Horstmann, T. Todenhofer, J. Hennenlotter et al., “Influence of age on false positive rates of urine-based tumor markers,” World Journal of Urology, vol. 31, no. 4, pp. 935–940, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Todenhofer, J. Hennenlotter, U. Kuhs et al., “Influence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder cancer,” Urology, vol. 79, no. 3, pp. 620–625, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Lodde, C. Mian, H. Wiener, A. Haitel, A. Pycha, and M. Marberger, “Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report,” Urology, vol. 58, no. 3, pp. 362–366, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. I. Toma, M. G. Friedrich, S. H. Hautmann et al., “Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer,” World Journal of Urology, vol. 22, no. 2, pp. 145–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. L. I. Budman, W. Kassouf, and J. R. Steinberg, “Biomarkers for detection and surveillance of bladder cancer,” Canadian Urological Association Journal, vol. 2, no. 3, pp. 212–221, 2008. View at Publisher · View at Google Scholar
  28. B. J. Schmitz-Drager, M. Droller, V. B. Lokeshwar et al., “Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus,” Urologia Internationalis, vol. 94, no. 1, pp. 1–24, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Skacel, M. Fahmy, J. A. Brainard et al., “Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology,” The Journal of Urology, vol. 169, no. 6, pp. 2101–2105, 2003. View at Publisher · View at Google Scholar · View at Scopus